Omid Farokhzad's guest appearances

Omid Farokhzad

Mendelspod Podcast

The Playbook With David Meltzer

Barack Obama

Neil Patel

Aubrey Marcus

Deepak Chopra

Alex Banayan

Mikey Taylor

Alex Mashinsky

Barbara Corcoran

Maria Sharapova

Janice Bryant Howroyd

Joe Dispenza

Marianne Williamson

Vanessa Hudgens

Brian Scudamore

Kara Goldin

OwlTail

Seer Inc

Are we now entering the age of proteomics the way we did with genomics thirty years ago?We were told we should talk to today’s guest by four people in one week.  He’s Omid Farokhzad, CEO and Founder of Seer Inc.  When we did, we understood why.Seer offers its customers the chance to “see the proteome in a way that’s never been possible before.”  So what does that mean?

Are we now entering the age of proteomics the way we did with genomics thirty years ago? We were told we should talk to today’s guest by four people in one week. He’s Omid Farokhzad, CEO and Founder of Seer Inc. When we did, we understood why. Seer offers its customers the chance to “see the proteome in a way that’s never been possible before.” So what does that mean?

Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.

Dr. Omid Farokhzad, Chair, CEO and Founder of Seer, sits down to discuss how Seer’s cutting edge work with protein and proteomics is removing technological barriers and providing scientists with better tools to make breakthroughs than ever before.Dr. Farokhzad and host of #ThePlaybook, David Meltzer, chat about a range of topics including the markets that will most benefit from proteomics and why Dr. Farokhzad says their company’s future goal is the diagnosis of disease at the pre-symptomatic level. The pair also share their thoughts on how Seer’s initial public offering in 2020 has impacted the way that the organization is run. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Omid Farokhzad, Chair, CEO and Founder of Seer, sits down to discuss how Seer’s cutting edge work with protein and proteomics is removing technological barriers and providing scientists with better tools to make breakthroughs than ever before.Dr. Farokhzad and host of #ThePlaybook, David Meltzer, chat about a range of topics including the markets that will most benefit from proteomics and why Dr. Farokhzad says their company’s future goal is the diagnosis of disease at the pre-symptomatic level. The pair also share their thoughts on how Seer’s initial public offering in 2020 has impacted the way that the organization is run. Learn more about your ad choices. Visit <a href="https://podcastchoices.com/adchoices" rel="nofollow" target="_blank">podcastchoices.com/adchoices</a>

Removing The Interference Between You and Your Health With Dr. Omid Farokhzad: CEO & Founder, Seer | #ThePlaybook 436